Source: The Motley Fool
The article recommends five dividend stocks with 50+ years of consecutive dividend increases as long-term holdings for 2027. Coca-Cola, Colgate-Palmolive, Procter & Gamble, PepsiCo, and Target are highlighted for their consistent dividend growth, strong free cash flow coverage, and expected 5-7% annual earnings growth over the next five years. Historical data shows dividend-paying stocks have returned 10.2% annually versus 4.2% for non-payers since 1973.
Source: Zacks Investment Research
Procter & Gamble, Church & Dwight, and Colgate-Palmolive are balancing premium product innovation with value offerings as consumers become increasingly price-sensitive. P&G reported 4% organic sales growth in Q1 FY2027 driven by volume and product mix, while managing inflation and competition pressures. All three companies are leveraging strong brand equity and differentiated portfolios across price points to sustain market share amid uncertain consumer spending.
Source: The Motley Fool
The article highlights three consumer dividend stocks—Colgate-Palmolive, McDonald's, and Target—that have each raised their dividends for 50+ consecutive years, demonstrating commitment to shareholders even during business challenges. These Dividend Kings maintained payout increases through stock price declines, sales struggles, and market volatility, making them attractive for income-focused investors seeking stability in uncertain markets.
Source: The Motley Fool
The article compares Colgate-Palmolive and Lululemon Athletica as investment options. Colgate offers steady dividend growth and stable demand for household essentials but faces margin pressure and high valuation multiples. Lululemon trades at a lower Forward P/E with stronger margins but is experiencing declining revenue and management uncertainty. The author recommends Colgate-Palmolive for its reliability and 63-year dividend increase streak, despite Lululemon's more attractive valuation metrics.
Source: The Motley Fool
Colgate-Palmolive reported Q3 2026 earnings with broad-based organic sales growth across four of five divisions. The company is leveraging dynamic pricing and cost-reduction programs to offset persistent raw material inflation while maintaining operating margins. Premium product innovation in Hill's Pet Nutrition is driving market share gains, and management remains optimistic about long-term growth prospects supported by revenue growth management and AI tools.
Source: Zacks Investment Research
Colgate-Palmolive (CL) reported Q3 2026 earnings of 97 cents per share, up 7% year-over-year and beating consensus estimates. Net sales grew 4.6% to $5.37 billion with 3.6% organic sales growth driven by balanced volume (1.7%) and pricing (2%) gains. The company raised its 2026 Base Business earnings growth guidance to 5-7% and expects gross margin expansion. Regional performance was mixed, with Latin America and Asia Pacific showing strong growth while North America declined.
Source: Zacks Investment Research
The Clorox Company (CLX) is set to report Q1 FY2027 results on Nov. 2, with consensus revenue expectations of $1.9 billion (31% YoY growth) and EPS of 97 cents (14.1% YoY growth). While product innovation, brand investments, and the GOJO/Purell acquisition are expected to support performance, the company faces headwinds from higher commodity and logistics costs, cautious consumer spending, and margin pressure. The Zacks model does not predict an earnings beat given CLX's +4.31% Earnings ESP combined with a Zacks Rank #4 (Sell).
Source: Zacks Investment Research
Colgate-Palmolive reported Q3 2026 earnings of $0.97 per share, beating consensus estimates of $0.92, with revenues of $5.37 billion exceeding expectations by 0.72%. The company has outperformed the market by 17.9% year-to-date. However, the stock received a Zacks Rank #3 (Hold) rating due to mixed earnings estimate revisions, suggesting near-term performance in line with the market. The Consumer Products - Staples industry ranks in the bottom 18% of Zacks industries.
Source: Zacks Investment Research
Kenvue Inc. is set to report Q3 2026 earnings on October 30, with consensus estimates at $3.9 billion in revenue (3.3% growth) and 28 cents EPS (flat YoY). While the company likely benefited from brand investments, e-commerce expansion, and strong demand for products like Zyrtec and Tylenol, inflationary pressures and margin headwinds pose challenges. The Zacks model does not predict an earnings beat, with KVUE showing 0% Earnings ESP and a Zacks Rank #4 (Sell).
Source: Zacks Investment Research
In a comparison of two Consumer Products - Staples sector stocks, BJ's Wholesale Club (BJ) emerges as the more attractive option for value investors compared to Colgate-Palmolive (CL). BJ holds a Zacks Rank of #2 (Buy) versus CL's #3 (Hold), and demonstrates superior valuation metrics including a lower forward P/E ratio (22.65 vs 24.05), better PEG ratio (3.12 vs 4.50), and significantly lower P/B ratio (6.11 vs 131.13). BJ received a Value grade of B while CL received a D grade.
Source: Zacks Investment Research
Zacks Premium offers investment research services including the Zacks Rank stock-rating system and Style Scores to help investors identify high-performing stocks. The system has historically outperformed the S&P 500 with an average annual return of +23.82% since 1988. Colgate-Palmolive is highlighted as a stock to watch with a #3 Hold rank and B VGM Score, showing solid growth prospects.
Source: Zacks Investment Research
Colgate-Palmolive is expected to report Q3 2026 results on October 30 with projected revenue growth of 3.9% to $5.33 billion and EPS growth of 1.1% to 92 cents. The company is anticipated to benefit from emerging market strength, premium oral-care innovation, Hill's Pet Nutrition performance, and cost-saving initiatives. However, its valuation appears relatively expensive at 23.32X forward P/E compared to the industry average of 20.16X.
Source: Zacks Investment Research
Newell Brands (NWL) is projected to report Q3 2026 revenues of $1.85B (+2.5% YoY) and EPS of 20 cents (+17.7% YoY) on October 30, 2026. The company is expected to benefit from product innovation, distribution gains, strong back-to-school execution, and margin expansion from its FUEL productivity program and pricing actions. With an Earnings ESP of +2.26% and Zacks Rank #3, the stock trades at an attractive valuation of 7.86X forward P/E, significantly below industry averages.
Source: The Motley Fool
The article compares Celsius, a high-growth functional energy drink company, against Colgate-Palmolive, a mature consumer staples leader. Celsius shows explosive 85.5% revenue growth but faces risks from Pepsi dependency and has declined 54% over the past year. Colgate-Palmolive offers defensive stability with consistent dividends (63 consecutive years of increases) and has outperformed the market with a 22% gain. The author recommends Colgate-Palmolive for its reliability and dividend consistency in uncertain economic times.
Source: Zacks Investment Research
Colgate-Palmolive is expected to report Q3 2026 earnings of $0.92 per share (up 1.1% YoY) with revenues of $5.33 billion (up 3.9% YoY) on October 30. The company has a positive Earnings ESP of +0.01% with a Zacks Rank #3 (Hold), suggesting it will likely beat consensus estimates. Colgate-Palmolive has beaten EPS estimates in all four of the last quarters.